For Oncology Nurses: Hormone Receptor-Positive Breast Cancer — Proceedings from the 2025 Annual ONS Congress
Research To Practice | Oncology Videos · Dr. Neil Love
June 16, 20251h 59m
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Featuring perspectives from Dr Virginia F Borges, Ms Jamie Carroll, Mr Ronald Stein and Dr Seth Wander, including the following topics:
- Introduction (0:00)
- Role of CDK4/6 Inhibitors in Localized and Metastatic Hormone Receptor (HR)-Positive Breast Cancer (12:49)
- PI3K Inhibition as First-Line Treatment for HR-Positive, HER2-Negative Metastatic Breast Cancer (mBC) (38:24)
- Clinical Utility of AKT and PI3K Inhibitors in Progressive HR-Positive mBC (1:01:44)
- Current and Future Role of Oral Selective Estrogen Receptor Degraders in HR-Positive mBC (1:24:38)